Advanced Cell Technology and Engineering Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

Advanced Cell Technology and Engineering General Information

Description

Developer of cell storage and regenerative medicine-related business based in Sapporo, Japan. The company offers regenerative medicine using stored cells through joint development with research institutions such as the National University Corporation Gifu University and pharmaceutical companies, enabling patients to improve dental pulp cells.

Contact Information

Formerly Known As
Regenerative Medicine Promotion Organization
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Shiroishi Ward, Kikusuimotomachi 8-jo 1-5-29
  • Sapporo, 003-0828
  • Japan
+81
Primary Industry
Other Healthcare Services
Parent Company
Dojin
Corporate Office
  • Shiroishi Ward, Kikusuimotomachi 8-jo 1-5-29
  • Sapporo, 003-0828
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced Cell Technology and Engineering Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 10-Jul-2020 Completed Generating Revenue
3. Merger/Acquisition 17-Jan-2019 Completed Generating Revenue
2. Later Stage VC 28-May-2018 Completed Generating Revenue
1. Later Stage VC (Series D) 30-Mar-2018 Completed Generating Revenue
To view Advanced Cell Technology and Engineering’s complete valuation and funding history, request access »

Advanced Cell Technology and Engineering Patents

Advanced Cell Technology and Engineering Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019216438-A1 Therapeutic agent for periodontal disease which contains culture supernatant of mesenchymal cell Inactive 11-May-2018
WO-2018143378-A1 Method for preparing dental pulp stem cells from cells derived from dental pulp tissue Inactive 03-Feb-2017
JP-WO2018143378-A1 Method for preparing dental pulp stem cells from dental pulp tissue-derived cells Pending 03-Feb-2017
WO-2018011989-A1 Graft material for treating nerve damage including dental pulp cells Inactive 15-Jul-2016
JP-WO2018011989-A1 Implants for treatment of nerve injury including dental pulp cells Active 15-Jul-2016 A61K35/32
To view Advanced Cell Technology and Engineering’s complete patent history, request access »

Advanced Cell Technology and Engineering Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advanced Cell Technology and Engineering Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kidswell Bio Corporation Majority
Angel (individual) Minority
Sekisui Chemical Corporation Minority
Sirius Partners (Tokyo) PE/Buyout Minority
To view Advanced Cell Technology and Engineering’s complete investors history, request access »

Advanced Cell Technology and Engineering FAQs

  • When was Advanced Cell Technology and Engineering founded?

    Advanced Cell Technology and Engineering was founded in 2008.

  • Where is Advanced Cell Technology and Engineering headquartered?

    Advanced Cell Technology and Engineering is headquartered in Sapporo, Japan.

  • What is the size of Advanced Cell Technology and Engineering?

    Advanced Cell Technology and Engineering has 1 total employees.

  • What industry is Advanced Cell Technology and Engineering in?

    Advanced Cell Technology and Engineering’s primary industry is Other Healthcare Services.

  • Is Advanced Cell Technology and Engineering a private or public company?

    Advanced Cell Technology and Engineering is a Private company.

  • What is Advanced Cell Technology and Engineering’s current revenue?

    The current revenue for Advanced Cell Technology and Engineering is .

  • Who are Advanced Cell Technology and Engineering’s investors?

    Kidswell Bio, , Sekisui Chemical, and Sirius Partners (Tokyo) have invested in Advanced Cell Technology and Engineering.

  • When was Advanced Cell Technology and Engineering acquired?

    Advanced Cell Technology and Engineering was acquired on 10-Jul-2020.

  • Who acquired Advanced Cell Technology and Engineering?

    Advanced Cell Technology and Engineering was acquired by Dojin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process